These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10797363)

  • 1. Serum type III procollagen in children with hepatoblastoma.
    Pitkänen S; Perkkiö M; Heikinheimo M
    Med Pediatr Oncol; 2000 May; 34(5):366-7. PubMed ID: 10797363
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
    Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
    Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we predict the prognosis of resectable hepatoblastoma from serum alpha-fetoprotein response during preoperative chemotherapy?
    Fukuzawa H; Urushihara N; Fukumoto K; Mitsunaga M; Watanabe K; Aoba T; Yamoto S; Miyake H; Hasegawa S
    Pediatr Surg Int; 2012 Sep; 28(9):887-91. PubMed ID: 22948667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
    Kubota M; Yagi M; Kanada S; Yamazaki S; Tanaka S; Asami K; Ogawa A; Watanabe A; Iwabuchi H; Kaneko M; Saida Y
    J Pediatr Surg; 2004 Dec; 39(12):1775-8. PubMed ID: 15616926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J; Brown J; Shafford E; Perilongo G; Brock P; Dicks-Mireaux C; Keeling J; Phillips A; Vos A; Plaschkes J
    J Clin Oncol; 2000 Nov; 18(22):3819-28. PubMed ID: 11078495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein.
    Tsuchida Y; Ikeda H; Suzuki N; Takahashi A; Kuroiwa M; Sakai M; Shimizu H; Shitara T; Yamanouchi H; Hirato J
    J Pediatr Surg; 1999 Dec; 34(12):1762-4. PubMed ID: 10626849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
    Davini M; Hastings C; Feusner J
    J Pediatr Hematol Oncol; 2024 May; 46(4):206-210. PubMed ID: 38551915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican 3 as a Serum Marker for Hepatoblastoma.
    Zhou S; O'Gorman MR; Yang F; Andresen K; Wang L
    Sci Rep; 2017 Apr; 7():45932. PubMed ID: 28378832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
    Van Tornout JM; Buckley JD; Quinn JJ; Feusner JH; Krailo MD; King DR; Hammond GD; Ortega JA
    J Clin Oncol; 1997 Mar; 15(3):1190-7. PubMed ID: 9060563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Liver Transplant For Hepatoblastoma: A Single-Center Experience.
    Kirnap M; Ayvazoglu Soy E; Ozcay F; Moray G; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):50-52. PubMed ID: 28260432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
    Nguyen R; McCarville MB; Sykes A; Mao S; Wu J; Langham MR; Furman WL
    Int J Clin Oncol; 2018 Oct; 23(5):900-907. PubMed ID: 29744604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is laparatomy the first step in treatment of childhood liver tumors?--The experience from the German Cooperative Pediatric Liver Tumor Study HB-89.
    von Schweinitz D; Bürger D; Mildenberger H
    Eur J Pediatr Surg; 1994 Apr; 4(2):82-6. PubMed ID: 7517696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.
    Rojas Y; Guillerman RP; Zhang W; Vasudevan SA; Nuchtern JG; Thompson PA
    Pediatr Radiol; 2014 Oct; 44(10):1275-80. PubMed ID: 24839140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
    Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
    Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of alpha-fetoprotein in children with primary hypothyroidism.
    Schwartz ID; Freeman AI; Grunt JA
    Arch Pediatr Adolesc Med; 1994 Feb; 148(2):225-7. PubMed ID: 7509701
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal serum alpha-fetoprotein and epithelial tumour marker concentrations are not increased by fetal sacrococcygeal teratoma.
    Kirkinen P; Heinonen S; Vanamo K; Ryynänen M
    Prenat Diagn; 1997 Jan; 17(1):47-50. PubMed ID: 9021828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics.
    Lovvorn HN; Ayers D; Zhao Z; Hilmes M; Prasad P; Shinall MC; Berch B; Neblett WW; O'Neill JA
    J Pediatr Surg; 2010 Jan; 45(1):121-8; discussion 129. PubMed ID: 20105591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating D-dimer level correlates with disease characteristics in hepatoblastoma patients.
    Zhang B; Liu G; Liu X; Zheng S; Dong K; Dong R
    Medicine (Baltimore); 2017 Nov; 96(47):e8798. PubMed ID: 29381980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of hepatocyte growth factor on hepatoblastoma.
    Tsunoda Y; Shibusawa M; Tsunoda A; Gomi A; Yatsuzuka M; Okamatsu T
    Anticancer Res; 1998; 18(6A):4339-42. PubMed ID: 9891489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.